BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19210288)

  • 1. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease.
    Wiggelinkhuizen M; Tilanus ME; Bollen CW; Houwen RH
    Aliment Pharmacol Ther; 2009 May; 29(9):947-58. PubMed ID: 19210288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
    Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
    Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
    Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Wilson Disease].
    Rev Prat; 2014 Apr; 64(4):564. PubMed ID: 24855798
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
    Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
    J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
    Schilsky M
    Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
    Rodríguez B; Burguera J; Berenguer M
    Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
    Tai CS; Wu JF; Chen HL; Hsu HY; Chang MH; Ni YH
    J Formos Med Assoc; 2018 May; 117(5):421-426. PubMed ID: 28578978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson disease: what is still unclear in pediatric patients?
    Ranucci G; Socha P; Iorio R
    Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):268-72. PubMed ID: 24745882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
    Selimoglu MA; Ertekin V; Doneray H; Yildirim M
    J Clin Gastroenterol; 2008 Feb; 42(2):194-8. PubMed ID: 18209591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilson disease.
    El-Youssef M
    Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
    Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
    J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
    Medici V; Rossaro L; Sturniolo GC
    Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Face of the giant panda' sign in Wilson disease.
    Thapa R; Ghosh A
    Pediatr Radiol; 2008 Dec; 38(12):1355. PubMed ID: 18839167
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.